Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daniel E Speiser
FcgRIIIA (CD16)-expressing Monocytes Mediate the Depletion of Tumor-Infiltrating Tregs via Ipilimumab-Dependent ADCC in Melanoma Patients
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
The HVEM Network: New Directions in Targeting Novel Costimulatory/Co-Inhibitory Molecules for Cancer Therapy
Current Opinion in Pharmacology
Drug Discovery
Pharmacology
Related publications
CD8+ Enriched "Young" Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Tumor-Infiltrating Lymphocytes in Melanoma
Current Oncology Reports
Oncology
Bevacizumab Plus Ipilimumab in Patients With Metastatic Melanoma
Cancer immunology research
Cancer Research
Immunology
Immunologic Heterogeneity of Tumor-Infiltrating Lymphocyte Composition in Primary Melanoma
Human Pathology
Forensic Medicine
Pathology
Linking Tumor Growth Dynamics to Survival in Ipilimumab‐Treated Patients With Advanced Melanoma Using Mixture Tumor Growth Dynamic Modeling
CPT: Pharmacometrics and Systems Pharmacology
Modeling
Simulation
Cardiovascular Medicine
Pharmacology
Cardiology
Ipilimumab for the Treatment of Advanced Melanoma in Six Kidney Transplant Patients
American Journal of Transplantation
Transplantation
Allergy
Immunology
Pharmacology
Multiplex Quantitative Analysis of Tumor-Infiltrating Lymphocytes and Immunotherapy Outcome in Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
Clinical Immunology Gastric Cancer Increase the Percentage of Intermediate (CD14++CD16+) and Nonclassical (CD14+CD16+) Monocytes
Central-European Journal of Immunology
Allergy
Immunology
Adjuvant Ipilimumab in High-Risk Uveal Melanoma
Cancers
Cancer Research
Oncology